Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron N Chang

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Hepatology (Baltimore, Md.)|August 6, 2013
MicroRNA-494 within an oncogenic microRNA megacluster regulates G1/S transition in liver tumorigenesis through suppression of mutated in colorectal cancerLionel Lim, Asha Balakrishnan, Noelle Huskey, et al.
The Journal of Clinical Investigation|June 8, 2011
Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosisKatey J Rayner, Frederick J Sheedy, Christine C Esau, et al.
Cell Cycle (Georgetown, Tex.)|August 5, 2009
MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNTZhan Zhang, Hong Sun, Hongyue Dai, et al.
Cell Reports|March 12, 2020
MYC Dysregulates Mitosis, Revealing Cancer VulnerabilitiesJulia Rohrberg, Daniel Van de Mark, Meelad Amouzgar, et al.
Science Translational Medicine|February 21, 2012
MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathwaysB Nelson Chau, Cuiyan Xin, Jochen Hartner, et al.
Oncotarget|March 2, 2016
Downregulation of 26S proteasome catalytic activity promotes epithelial-mesenchymal transitionAsoka Banno, Daniel A Garcia, Eric D van Baarsel, et al.
Biological Psychiatry|November 13, 2022
Fragile X Syndrome Patient-Derived Neurons Developing in the Mouse Brain Show FMR1-Dependent PhenotypesMarine A Krzisch, Hao Wu, Bingbing Yuan, et al.
Nature Methods|March 21, 2017
Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactionsJohn Paul Shen, Dongxin Zhao, Roman Sasik, et al.
The Journal of Clinical Investigation|August 29, 2017
Proteasome activity regulates CD8+ T lymphocyte metabolism and fate specificationChristella E Widjaja, Jocelyn G Olvera, Patrick J Metz, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Hepatology (Baltimore, Md.)|August 6, 2013
MicroRNA-494 within an oncogenic microRNA megacluster regulates G1/S transition in liver tumorigenesis through suppression of mutated in colorectal cancerLionel Lim, Asha Balakrishnan, Noelle Huskey, et al.
The Journal of Clinical Investigation|June 8, 2011
Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosisKatey J Rayner, Frederick J Sheedy, Christine C Esau, et al.
Cell Cycle (Georgetown, Tex.)|August 5, 2009
MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNTZhan Zhang, Hong Sun, Hongyue Dai, et al.
Cell Reports|March 12, 2020
MYC Dysregulates Mitosis, Revealing Cancer VulnerabilitiesJulia Rohrberg, Daniel Van de Mark, Meelad Amouzgar, et al.
Science Translational Medicine|February 21, 2012
MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathwaysB Nelson Chau, Cuiyan Xin, Jochen Hartner, et al.
Oncotarget|March 2, 2016
Downregulation of 26S proteasome catalytic activity promotes epithelial-mesenchymal transitionAsoka Banno, Daniel A Garcia, Eric D van Baarsel, et al.
Biological Psychiatry|November 13, 2022
Fragile X Syndrome Patient-Derived Neurons Developing in the Mouse Brain Show FMR1-Dependent PhenotypesMarine A Krzisch, Hao Wu, Bingbing Yuan, et al.
Nature Methods|March 21, 2017
Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactionsJohn Paul Shen, Dongxin Zhao, Roman Sasik, et al.
The Journal of Clinical Investigation|August 29, 2017
Proteasome activity regulates CD8+ T lymphocyte metabolism and fate specificationChristella E Widjaja, Jocelyn G Olvera, Patrick J Metz, et al.
Pageof 3